Vivani Medical VANI Neurostimulation Division — Other Nonoperating Income Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's neurostimulation division — other nonoperating income expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Vivani Medical's neurostimulation division — other nonoperating income expense?
- Vivani Medical (VANI) reported neurostimulation division — other nonoperating income expense of $31.5K in Q4 2025.
- How has Vivani Medical's neurostimulation division — other nonoperating income expense changed year-over-year?
- Vivani Medical's neurostimulation division — other nonoperating income expense increased by 180.8% year-over-year, from -$39K to $31.5K.
- What is the long-term trend for Vivani Medical's neurostimulation division — other nonoperating income expense?
- Over 2 years (2023 to 2025), Vivani Medical's neurostimulation division — other nonoperating income expense has grown at a 5.6% compound annual growth rate (CAGR), from -$113K to $126K.
- What does neurostimulation division — other nonoperating income expense mean?
- Includes financial items outside the core business operations of the neurostimulation division, such as interest income, interest expense, or foreign exchange gains and losses. This metric provides insight into the division's peripheral financial activities and non-core cash flow impacts. It helps isolate the performance of the primary business from incidental financial events.